--- title: Posture in Abdominopelvic Training in Women SUI nct_id: NCT03727945 overall_status: COMPLETED phase: NA sponsor: University of Valencia study_type: INTERVENTIONAL primary_condition: Female Stress Incontinence canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03727945.md" clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03727945" ct_last_update_post_date: 2018-11-01 last_seen_at: "2026-05-12T07:12:42.885Z" source: ClinicalTrials.gov (mirrored, no enrichment) --- # Posture in Abdominopelvic Training in Women SUI **Official Title:** Posture Correction in Abdominopelvic Training in Women With Stress Urinary Incontinence **NCT ID:** [NCT03727945](https://clinicaltrials.gov/study/NCT03727945) ## Key Facts - **Status:** COMPLETED - **Phase:** NA - **Study Type:** INTERVENTIONAL - **Target Enrollment:** 49 - **Lead Sponsor:** University of Valencia - **Conditions:** Female Stress Incontinence - **Start Date:** 2014-09 - **Completion Date:** 2016-09 - **CT.gov Last Update:** 2018-11-01 ## Brief Summary Measure effect of postural correction in abdominopelvic exercises on the improvement of the quality of life in patients with SUI. 42 women aged between 46-75 with SUI and stress-predominant mixed urinary incontinence. There were randomly assigned two groups of different treatment. Quality of life was measured by questionnaires: Incontinence Questionnaire Short Form (ICIQ-IU-SF) and King's Health Questionnaire (KHQ) global punctuation and incontinence impact. Treatment satisfaction was measured by VAS scale. ## Detailed Description The aim of this study was compare the effect of postural correction in abdominopelvic exercises on the improvement of the quality of life in patients with stress urinary incontinence (SUI). Was a randomized 2-treatment parallel design study. The sample consist in 42 women aged between 46-75 with stress urinary incontinence (SUI) and stress-predominant mixed urinary incontinence (IUM). They were randomly assigned to two groups: Group 1 (n=21) who received abdomino-pelvic training, and Group 2(n=21) who received the above treatment, guidelines about postural correction. Both groups received 12 treatment sessions in first session information regarding clinical and demographical aspects will be collected. To evaluate results of postural correction combined with abdominopelvic exercise women was assessed:at initial session, post- intervention and 3 months post-intervention treatment.Quality of life was measured by spanish validation questionnaires: International Continence Questionnaire Short Form (ICIQ-IU-SF) and King's Health Questionnaire (KHQ) global punctuation and incontinence impact. Treatment satisfaction was measured by Visual analogic scale (VAS). ## Eligibility - **Minimum age:** 45 Years - **Maximum age:** 75 Years - **Sex:** FEMALE - **Healthy Volunteers:** No ``` Inclusion Criteria: * SUI or stress-predominant mixed UI * diagnosed via clinical assessment and urodynamic study * Estrogenic deficit.: perimenopause, menopause, postmenopause Exclusion Criteria: * grade 3-4 prolapse, * functional alterations (Barthel Scale \> 85 points), * neurological or cognitive alterations (mini mental examination \> 24 points) * other predominant type of urinary incontinence. ``` ## Arms - **abdominopelvic exercise and posture** (EXPERIMENTAL) — N=21 received supervised physiotherapy abdominopelvic exercise previous postural correction. - **abdominopelvic exercise** (EXPERIMENTAL) — N=21 received supervised physiotherapy abdominopelvic exercise. ## Interventions - **abdominopelvic exercise and posture** (OTHER) — n=21 women received supervised abdominopelvic exercise with previous postural correction. During 12 sessions a specialized physiotherapist supervised to realization of progressive abdominopelvic exercises, previous explain postural correction pelvis, cervical and dorsal zone. - **abdominopelvic exercise** (OTHER) — n=21 women received supervised abdominopelvic exercise. During 12 sessions a specialized physiotherapist supervised to realization of progressive abdominopelvic exercises. ## Primary Outcomes - **Changes from Quality of life. KHQ** _(time frame: baseline,3 months,6 months)_ — The questionnaire KHQ consists of 30 items distributed in 9 dimensions that we expose below, the scores of this questionnaire vary from 0 to 100, each item presents a scale type Likert with four options of response. The score of the KHQ questionnaire can be globally with a range of 0 (which indicates better health-related quality of life) at 100 points (indicating a worse quality of life) - **Changes from Quality of life. ICIQ-IU-SF** _(time frame: baseline,3 months, 6 months)_ — t consists of four questions that assess the presence of urge urinary incontinence, the amount of fluid evacuated and the involvement of the quality of life. The final score oscillates from 0-21, indicating higher scores to greater severity of the IU. - **Treatment satisfaction** _(time frame: 3 months)_ — Visual analogic scale (VAS, 0-10, 0=minimum score, 10=maximum score). Higher values represent a better outcome (less treatment satisfaction) - **Changes from IU impact. KHQ** _(time frame: baseline,3 months, 6 months)_ — Question nº2 of KHQ measured IU impact in patient's life. Is a Likert scale 0-4 punctuation ( 0= no proceed, 4= A lot) - **Changes from IU impact.ICIQ-IU-SF** _(time frame: Initial,3 months, 6 months)_ — Question nº3 of ICIQ-IU-SF, measured IU impact in patient's life.Is a numeric scale (1-10),(1= none and 10= a lot ) ## Recent Field Changes (last 30 days) - `status.overallStatus` — added _(2026-05-12)_ - `status.primaryCompletionDate` — added _(2026-05-12)_ - `status.completionDate` — added _(2026-05-12)_ - `status.lastUpdatePostDate` — added _(2026-05-12)_ - `design.phases` — added _(2026-05-12)_ - `design.enrollmentCount` — added _(2026-05-12)_ - `eligibility.criteria` — added _(2026-05-12)_ - `eligibility.minAge` — added _(2026-05-12)_ - `eligibility.maxAge` — added _(2026-05-12)_ - `eligibility.sex` — added _(2026-05-12)_ - `outcomes.primary` — added _(2026-05-12)_ - `armsInterventions.arms` — added _(2026-05-12)_ - `armsInterventions.interventions` — added _(2026-05-12)_ - `sponsor.lead` — added _(2026-05-12)_ - `results.hasResults` — added _(2026-05-12)_ --- *Canonical: https://parkinsonspathways.com/agent/trials/NCT03727945.md* *Source data (authoritative): https://clinicaltrials.gov/study/NCT03727945* *This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*